AbbVie (ABBV) Revenue — Quarter Ended Dec 31, 2023
Revenue for the quarter increased compared to the immediately preceding quarter. However, revenue declined relative to the same quarter one year earlier.
Key takeaway
Quarter ended Dec 31, 2023 · FY2023 FY
Revenue for the quarter increased compared to the immediately preceding quarter. However, revenue declined relative to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$14.3B
Revenue reported for this quarter.
Quarter-over-quarter
+2.7%
Change from the immediately preceding quarter.
Year-over-year
-5.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$54.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2023 | $12.2B | -9.7% |
| Jun 30, 2023 | $13.9B | -4.9% |
| Sep 30, 2023 | $13.9B | -6.0% |
| Dec 31, 2023 | $14.3B | -5.4% |
Revenue performance
The reported revenue direction was upward from the prior quarter, reversing the sequential declines seen in earlier periods of the year.
Quarterly comparison
Compared with the immediately preceding quarter, revenue rose. Compared with the same quarter one year earlier, revenue was lower, consistent with the year-over-year declines observed throughout the year.
What to watch
The filing context notes that operating cash flows decreased from the prior year due to lower net revenues and higher income tax payments.